• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌切除术后呼出羰基化合物的归一化

Normalization of Exhaled Carbonyl Compounds After Lung Cancer Resection.

作者信息

Schumer Erin M, Black Matthew C, Bousamra Michael, Trivedi Jaimin R, Li Mingxiao, Fu Xiao-An, van Berkel Victor

机构信息

Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, Kentucky.

Department of Chemical Engineering, University of Louisville, Louisville, Kentucky.

出版信息

Ann Thorac Surg. 2016 Oct;102(4):1095-100. doi: 10.1016/j.athoracsur.2016.04.068. Epub 2016 Jun 9.

DOI:10.1016/j.athoracsur.2016.04.068
PMID:27293148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5042568/
Abstract

BACKGROUND

Quantitative analysis of specific exhaled carbonyl compounds (ECCs) has shown promise for the detection of lung cancer. The purpose of this study is to demonstrate the normalization of ECCs in patients after lung cancer resection.

METHODS

Patients from a single center gave consent and were enrolled in the study from 2011 onward. Breath analysis was performed on lung cancer patients before and after surgical resection of their tumors. One liter of breath from a single exhalation was collected and evacuated over a silicon microchip. Carbonyls were captured by oximation reaction and analyzed by mass spectrometry. Concentrations of four cancer-specific ECCs were measured and compared by using the Wilcoxon test. A given cancer marker was considered elevated at 1.5 or more standard deviations greater than the mean of the control population.

RESULTS

There were 34 cancer patients with paired samples and 187 control subjects. The median values after resection were significantly lower for all four ECCs and were equivalent to the control patient values for three of the four ECCs.

CONCLUSIONS

The analysis of ECCs demonstrates reduction to the level of control patients after surgical resection for lung cancer. This technology has the potential to be a useful tool to detect disease after lung cancer resection. Continued follow-up will determine whether subsequent elevation of ECCs is indicative of recurrent disease.

摘要

背景

对特定呼出羰基化合物(ECCs)的定量分析已显示出在肺癌检测方面的前景。本研究的目的是证明肺癌切除术后患者ECCs的正常化。

方法

来自单一中心的患者自2011年起同意参与本研究。对肺癌患者在肿瘤手术切除前后进行呼吸分析。从单次呼气中收集1升呼出气体,并通过硅微芯片进行抽气。羰基化合物通过肟化反应捕获,并通过质谱分析。使用Wilcoxon检验测量并比较四种癌症特异性ECCs的浓度。若某一特定癌症标志物的值比对照人群的平均值高出1.5个或更多标准差,则认为该标志物升高。

结果

有34例癌症患者有配对样本,187例对照受试者。切除术后所有四种ECCs的中位数显著降低,且四种ECCs中的三种相当于对照患者的值。

结论

ECCs分析表明,肺癌手术切除后ECCs水平降至对照患者水平。这项技术有可能成为检测肺癌切除术后疾病的有用工具。持续随访将确定ECCs随后升高是否表明疾病复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e64/5042568/6d3ac47b8d50/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e64/5042568/99fd4d9eb99b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e64/5042568/6d3ac47b8d50/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e64/5042568/99fd4d9eb99b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e64/5042568/6d3ac47b8d50/gr2.jpg

相似文献

1
Normalization of Exhaled Carbonyl Compounds After Lung Cancer Resection.肺癌切除术后呼出羰基化合物的归一化
Ann Thorac Surg. 2016 Oct;102(4):1095-100. doi: 10.1016/j.athoracsur.2016.04.068. Epub 2016 Jun 9.
2
High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds.利用呼出羰基化合物分析对肺癌检测具有高灵敏度。
J Thorac Cardiovasc Surg. 2015 Dec;150(6):1517-22; discussion 1522-4. doi: 10.1016/j.jtcvs.2015.08.092. Epub 2015 Aug 31.
3
Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.呼出羰基化合物的定量分析可区分良性和恶性肺部疾病。
J Thorac Cardiovasc Surg. 2014 Sep;148(3):1074-80; discussion 1080-1. doi: 10.1016/j.jtcvs.2014.06.006. Epub 2014 Jun 8.
4
Breath carbonyl compounds as biomarkers of lung cancer.呼气羰基化合物作为肺癌的生物标志物。
Lung Cancer. 2015 Oct;90(1):92-7. doi: 10.1016/j.lungcan.2015.07.005. Epub 2015 Jul 19.
5
Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer.呼气分析在晚期肺癌治疗反应监测中的应用。
J Thorac Oncol. 2016 Jun;11(6):827-37. doi: 10.1016/j.jtho.2016.02.017. Epub 2016 Mar 9.
6
Real-time ultrasensitive VUV-PIMS detection of representative endogenous volatile markers in cancers.癌症中代表性内源性挥发性标志物的实时超灵敏真空紫外光电离质谱检测
Cancer Biomark. 2016;16(3):477-87. doi: 10.3233/CBM-160587.
7
Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.基于联用分离技术和化学计量学的肺癌生物标志物研究。
Clin Chem Lab Med. 2011 Oct 28;50(3):573-81. doi: 10.1515/CCLM.2011.769.
8
Noninvasive detection of lung cancer using exhaled breath.使用呼气检测肺癌。
Cancer Med. 2014 Feb;3(1):174-81. doi: 10.1002/cam4.162. Epub 2013 Nov 20.
9
Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.回顾近年来在呼气中挥发性有机化合物作为肺癌诊断生物标志物的测定方面的进展。
Anal Chim Acta. 2017 Dec 15;996:1-9. doi: 10.1016/j.aca.2017.09.021. Epub 2017 Sep 13.
10
Progress in the development of volatile exhaled breath signatures of lung cancer.肺癌挥发性呼出气体特征的研究进展。
Ann Am Thorac Soc. 2015 May;12(5):752-7. doi: 10.1513/AnnalsATS.201411-540OC.

引用本文的文献

1
Detection of Exhaled Volatile Organic Compounds as Noninvasive Biomarkers for Pancreatic Adenocarcinoma.检测呼出的挥发性有机化合物作为胰腺癌的非侵入性生物标志物。
Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17685-z.
2
The human volatilome meets cancer diagnostics: past, present, and future of noninvasive applications.人类挥发物组分析技术在癌症诊断中的应用:非侵入性应用的过去、现在和未来。
Metabolomics. 2024 Oct 7;20(5):113. doi: 10.1007/s11306-024-02180-5.
3
Identification of a marker of infection in the breath using a porcine pneumonia model.

本文引用的文献

1
Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.肺癌呼吸生物标志物的盲法验证:胸部CT筛查的潜在辅助手段
PLoS One. 2015 Dec 23;10(12):e0142484. doi: 10.1371/journal.pone.0142484. eCollection 2015.
2
High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds.利用呼出羰基化合物分析对肺癌检测具有高灵敏度。
J Thorac Cardiovasc Surg. 2015 Dec;150(6):1517-22; discussion 1522-4. doi: 10.1016/j.jtcvs.2015.08.092. Epub 2015 Aug 31.
3
Current estimate of costs of lung cancer screening in the United States.
利用猪肺炎模型鉴定呼出气体中的感染标志物。
JTCVS Open. 2023 Oct 30;16:1063-1069. doi: 10.1016/j.xjon.2023.10.025. eCollection 2023 Dec.
4
The Use of Breath Analysis in the Management of Lung Cancer: Is It Ready for Primetime?呼气分析在肺癌管理中的应用:是否已经成熟?
Curr Oncol. 2022 Sep 30;29(10):7355-7378. doi: 10.3390/curroncol29100578.
5
Lipid Peroxidation Produces a Diverse Mixture of Saturated and Unsaturated Aldehydes in Exhaled Breath That Can Serve as Biomarkers of Lung Cancer-A Review.脂质过氧化在呼出气体中产生饱和醛和不饱和醛的多种混合物,可作为肺癌的生物标志物——综述
Metabolites. 2022 Jun 18;12(6):561. doi: 10.3390/metabo12060561.
6
A novel technology to integrate imaging and clinical markers for non-invasive diagnosis of lung cancer.一种用于非侵入性诊断肺癌的新型成像与临床标志物整合技术。
Sci Rep. 2021 Feb 25;11(1):4597. doi: 10.1038/s41598-021-83907-5.
7
Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.基于挥发性有机化合物的呼气测试用于癌症诊断的准确性和方法学挑战:系统评价和荟萃分析。
JAMA Oncol. 2019 Jan 1;5(1):e182815. doi: 10.1001/jamaoncol.2018.2815. Epub 2019 Jan 10.
8
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans.氧化应激生物标志物的测量及其在人类中的临床意义。
Oxid Med Cell Longev. 2017;2017:6501046. doi: 10.1155/2017/6501046. Epub 2017 Jun 18.
美国肺癌筛查当前的成本估算。
Thorac Surg Clin. 2015 May;25(2):205-15. doi: 10.1016/j.thorsurg.2014.12.005. Epub 2015 Mar 7.
4
Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.国家肺癌筛查试验中Lung-RADS的表现:一项回顾性评估
Ann Intern Med. 2015 Apr 7;162(7):485-91. doi: 10.7326/M14-2086.
5
PSA testing for prostate cancer screening.用于前列腺癌筛查的前列腺特异性抗原检测
Lancet Oncol. 2015 Jan;16(1):e2-3. doi: 10.1016/S1470-2045(14)71108-8. Epub 2014 Dec 29.
6
Cost-effectiveness of CT screening in the National Lung Screening Trial.国家肺癌筛查试验中CT筛查的成本效益
N Engl J Med. 2015 Jan 22;372(4):388. doi: 10.1056/NEJMc1414726.
7
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
8
Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.基于监测、流行病学和最终结果(SEER)登记处的肺癌分期及临床/预后因素分析:美国癌症联合委员会(AJCC)分期与协作分期数据收集系统
Cancer. 2014 Dec 1;120 Suppl 23(0 0):3781-92. doi: 10.1002/cncr.29045.
9
Does the method of radiologic surveillance affect survival after resection of stage I non-small cell lung cancer?放射监测方法是否会影响 I 期非小细胞肺癌切除术后的生存?
J Thorac Cardiovasc Surg. 2015 Jan;149(1):45-52, 53.e1-3. doi: 10.1016/j.jtcvs.2014.07.095. Epub 2014 Aug 8.
10
Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.呼出羰基化合物的定量分析可区分良性和恶性肺部疾病。
J Thorac Cardiovasc Surg. 2014 Sep;148(3):1074-80; discussion 1080-1. doi: 10.1016/j.jtcvs.2014.06.006. Epub 2014 Jun 8.